Danaher (DHR) Coverage Initiated by Analysts at UBS Group

UBS Group began coverage on shares of Danaher (NYSE:DHR) in a report issued on Monday morning. The brokerage issued a buy rating and a $99.97 target price on the conglomerate’s stock.

A number of other brokerages have also recently issued reports on DHR. Citigroup increased their price objective on Danaher to $107.00 and gave the stock a buy rating in a report on Friday, December 15th. Robert W. Baird reissued a buy rating on shares of Danaher in a report on Friday, January 12th. Goldman Sachs Group reissued a neutral rating and set a $83.00 price objective on shares of Danaher in a report on Tuesday, September 26th. Royal Bank of Canada reissued a hold rating and set a $96.00 price objective on shares of Danaher in a report on Thursday, January 4th. Finally, Credit Suisse Group increased their price objective on Danaher from $93.00 to $96.00 and gave the stock an outperform rating in a report on Friday, October 20th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. Danaher has a consensus rating of Buy and a consensus target price of $96.10.

Shares of Danaher (NYSE:DHR) traded down $0.59 during midday trading on Monday, hitting $99.97. The stock had a trading volume of 2,163,100 shares, compared to its average volume of 2,412,800. Danaher has a 1 year low of $78.97 and a 1 year high of $100.88. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. The stock has a market cap of $69,540.00, a PE ratio of 29.75, a PEG ratio of 2.18 and a beta of 1.03.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a $0.14 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.56%. Danaher’s dividend payout ratio is currently 16.67%.

In other Danaher news, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total value of $11,671,620.96. Following the completion of the transaction, the chief executive officer now owns 271,737 shares in the company, valued at $25,173,715.68. The disclosure for this sale can be found here. 12.20% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Rothschild Investment Corp IL increased its position in shares of Danaher by 3.8% during the 4th quarter. Rothschild Investment Corp IL now owns 19,207 shares of the conglomerate’s stock valued at $1,783,000 after purchasing an additional 700 shares during the last quarter. UMB Bank N A MO increased its position in shares of Danaher by 6.5% during the 4th quarter. UMB Bank N A MO now owns 71,888 shares of the conglomerate’s stock valued at $6,673,000 after purchasing an additional 4,379 shares during the last quarter. Eastern Bank increased its position in shares of Danaher by 2.2% during the 4th quarter. Eastern Bank now owns 130,282 shares of the conglomerate’s stock valued at $12,092,000 after purchasing an additional 2,793 shares during the last quarter. North American Management Corp increased its position in shares of Danaher by 0.4% during the 4th quarter. North American Management Corp now owns 123,093 shares of the conglomerate’s stock valued at $11,426,000 after purchasing an additional 512 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC increased its position in shares of Danaher by 71.7% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 7,804 shares of the conglomerate’s stock valued at $724,000 after purchasing an additional 3,259 shares during the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Danaher (DHR) Coverage Initiated by Analysts at UBS Group” was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://ledgergazette.com/2018/01/23/danaher-dhr-coverage-initiated-by-analysts-at-ubs-group.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply